drugset

drugset / Trial / NCT01401413

Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder

NCT01401413 ↗

Phase 4 Completed 20 enrolled Sleep Medicine Centers of WNY

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the use of the drug ramelteon decreases the symptoms of REM Sleep Behavior Disorder.

Timeline

Start: 2008-01
Primary completion: 2010-09
Completion: 2010-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Ramelteon	Unknown	8 mg	—

Indications